LFMD LIFEMD INC

LifeMD to Report Second Quarter 2023 Financial Results on August 9

LifeMD to Report Second Quarter 2023 Financial Results on August 9

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended June 30, 2023 after the close of the U.S. financial markets on August 9, 2023 and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date:Wednesday, August 9th
Time:4:30 p.m. Eastern Time
Toll-Free Dial-In:1-877-704-4453
International Dial-In:1-201-389-0920
Conference ID:13739131
Live & Archived Webcast:



About LifeMD


LifeMD is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to .

Media Contact

Investor Contact

Marc Benathen, CFO



EN
26/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2025, to holders of record at the close of business on July 3, 2025. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. ...

 PRESS RELEASE

LifeMD to Participate in Two Investor Conferences During June

LifeMD to Participate in Two Investor Conferences During June NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 18. Management will participate in a virtual panel discussion titled “Direct to Consumer vs. Direct to Enterprise” at 2:00 p.m. Eastern time. Institutional investors can register for the conference by contacting their BTIG representative or by clicking . Truist Securi...

 PRESS RELEASE

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bund...

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy® Bundled Offer Includes Wegovy® at $199 and LifeMD’s Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD’s virtual weight management program. As part of it...

 PRESS RELEASE

LifeMD to Participate in Three Investor Conferences During May

LifeMD to Participate in Three Investor Conferences During May NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May: H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will be holding one-on-one meetings with investors.B. Riley Securities 25th Annual Institutional Investor Conference, May 21-22 at the Ritz-Carlton in Marina Del Rey. Management will be presenting...

 PRESS RELEASE

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Gu...

LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70%Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago periodTelehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago periodGAAP net income of $0.6 million or $0.01 per diluted share, delivering first-ever quarter of positive GAAP EPSRaising full-year 2025 guidance for both total revenues and adjusted EBITDA, reflecting strong year-to-date performance in telehealth ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch